NCT02497300View on ClinicalTrials.gov

Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 31, 2021

Study Completion Date

July 31, 2021

Conditions
Chronic Kidney DiseaseAlbuminuria
Interventions
DRUG

Spironolactone

DRUG

Amiloride

Trial Locations (1)

35294

Hypertension Research Clinic at UAB, Birmingham

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Alabama at Birmingham

OTHER

NCT02497300 - Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease | Biotech Hunter | Biotech Hunter